
Opinion|Videos|July 23, 2026
Pharmacist-Led Toxicity Management in Menin Inhibitor Therapy
In this episode, Ali outlines the non-negotiable items on the first-fill consultation checklist, including baseline ECG requirements, medication review for drug interactions, and enrollment in manufacturer support programs.
Advertisement
Episodes in this series

In this episode, Ali outlines the non-negotiable items on the first-fill consultation checklist, including baseline ECG requirements, medication review for drug interactions, and enrollment in manufacturer support programs. He provides detailed counseling guidance on differentiation syndrome—the class-defining toxicity—and explains what action thresholds cross the line from monitoring to intervention.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKD Outcome Set Elevates Patient-Reported Measures
2
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
3
Evolocumab Cuts MACE in At-Risk Patients With No Prior Events in VESALIUS-CV
4
FDA Approves Camizestrant for ESR1-Mutated Breast Cancer
5



































































































